Pfizer reports loss as it eyes big oncology push

Pfizer reported a quarterly loss Tuesday on much lower sales of Covid-19 products as it emphasized progress on cost-cutting and drug development initiatives. The big US pharma company, which has been credited with critical Covid-19 vaccines and Paxlovid therapeutic, described itself as on track with a transition to a post-pandemic environment that includes a heavy […]

The post Pfizer reports loss as it eyes big oncology push appeared first on Insider Paper.